{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:22:43Z","timestamp":1787887363736,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00330-021-08407-6","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:03:06Z","timestamp":1642118586000},"page":"2330-2339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Risk-based MRI-directed diagnostic pathway outperforms non-risk-based pathways in suspected prostate cancer biopsy-na\u00efve men: a large cohort validation study"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9175-9626","authenticated-orcid":false,"given":"Leonardo Kayat","family":"Bittencourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Guricova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Zucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared C.","family":"Durieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo G.","family":"Schoots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"8407_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging\u2013reporting and data system: 2015, version 2. Eur Urol 69:16\u201340","journal-title":"Eur Urol"},{"key":"8407_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2. Eur Urol 76:340\u2013351","journal-title":"Eur Urol"},{"key":"8407_CR3","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767\u20131777","journal-title":"N Engl J Med"},{"key":"8407_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouvi\u00e8re","year":"2019","unstructured":"Rouvi\u00e8re O, Puech P, Renard-Penna R et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100\u2013109","journal-title":"Lancet Oncol"},{"key":"8407_CR5","unstructured":"Mottet N, Bellmunt J, Briers E, et al (2018) EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer. European Association of Urology. Available at: https:\/\/uroweb.org\/wp-content\/uploads\/Prostate-Cancer-2017-pocket.pdf"},{"key":"8407_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler JL, Antonarakis ES, Armstrong AJ et al (2019) Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17:479\u2013505","journal-title":"J Natl Compr Canc Netw"},{"key":"8407_CR7","first-page":"832","volume":"198","author":"MA Bjurlin","year":"2019","unstructured":"Bjurlin MA, Carroll PR, Eggener S et al (2019) Update of the AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer. J Urol 198:832\u2013838","journal-title":"J Urol"},{"key":"8407_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","volume":"71","author":"M Borghesi","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R et al (2017) Complications after systematic, random, and image-guided prostate biopsy. Eur Urol 71:353\u2013365","journal-title":"Eur Urol"},{"key":"8407_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","volume":"77","author":"F-JH Drost","year":"2020","unstructured":"Drost F-JH, Osses D, Nieboer D et al (2020) Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis. Eur Urol 77:78\u201394","journal-title":"Eur Urol"},{"key":"8407_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.eururo.2019.04.043","volume":"76","author":"V Kasivisvanathan","year":"2019","unstructured":"Kasivisvanathan V, Stabile A, Neves JB et al (2019) Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis. Eur Urol 76:284\u2013303","journal-title":"Eur Urol"},{"key":"8407_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.euo.2019.10.001","volume":"3","author":"IG Schoots","year":"2020","unstructured":"Schoots IG, Padhani AR, Rouvi\u00e8re O et al (2020) Analysis of magnetic resonance imaging\u2013directed biopsy strategies for changing the paradigm of prostate cancer diagnosis. Eur Urol Oncol 3:32\u201341. https:\/\/doi.org\/10.1016\/j.euo.2019.10.001","journal-title":"Eur Urol Oncol"},{"key":"8407_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.2019182946","volume":"292","author":"AR Padhani","year":"2019","unstructured":"Padhani AR, Barentsz J, Villeirs G et al (2019) PI-RADS Steering Committee: the PI-RADS multiparametric MRI and MRI-directed biopsy pathway. Radiology 292:464\u2013474. https:\/\/doi.org\/10.1148\/radiol.2019182946","journal-title":"Radiology"},{"key":"8407_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.euo.2018.09.001","volume":"2","author":"L Boesen","year":"2019","unstructured":"Boesen L, N\u00f8rgaard N, L\u00f8gager V et al (2019) Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7\u201310 prostate cancer in biopsy-na\u00efve men. Eur Urol Oncol 2:311\u2013319","journal-title":"Eur Urol Oncol"},{"key":"8407_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.euo.2019.08.008","volume":"3","author":"J Knaapila","year":"2020","unstructured":"Knaapila J, Jambor I, Perez IM et al (2020) Prebiopsy IMPROD biparametric magnetic resonance imaging combined with prostate-specific antigen density in the diagnosis of prostate cancer: an external validation study. Eur Urol Oncol 3:648\u2013656","journal-title":"Eur Urol Oncol"},{"key":"8407_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bju.15277","volume":"127","author":"IG Schoots","year":"2021","unstructured":"Schoots IG, Padhani AR (2021) Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int 127:175\u2013178. https:\/\/doi.org\/10.1111\/bju.15277","journal-title":"BJU Int"},{"key":"8407_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","volume":"64","author":"CM Moore","year":"2013","unstructured":"Moore CM, Kasivisvanathan V, Eggener S et al (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an international working group. Eur Urol 64:544\u2013552. https:\/\/doi.org\/10.1016\/j.eururo.2013.03.030","journal-title":"Eur Urol"},{"key":"8407_CR17","doi-asserted-by":"publisher","unstructured":"Vickers AJ, Van Calster B, Steyerberg EW (2016) Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ 352:i6. https:\/\/doi.org\/10.1136\/bmj.i6","DOI":"10.1136\/bmj.i6"},{"key":"8407_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jama.2015.37","volume":"313","author":"M Fitzgerald","year":"2015","unstructured":"Fitzgerald M, Saville BR, Lewis RJ (2015) Decision curve analysis. JAMA 313:409. https:\/\/doi.org\/10.1001\/jama.2015.37","journal-title":"JAMA"},{"key":"8407_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","volume":"3","author":"AJ Vickers","year":"2019","unstructured":"Vickers AJ, van Calster B, Steyerberg EW (2019) A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res 3:18. https:\/\/doi.org\/10.1186\/s41512-019-0064-7","journal-title":"Diagn Progn Res"},{"key":"8407_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, Wynants L, Verbeek JFM et al (2018) Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol 74:796\u2013804. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.038","journal-title":"Eur Urol"},{"key":"8407_CR21","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","volume":"360","author":"GL Andriole","year":"2009","unstructured":"Andriole GL, Crawford ED, Grubb RL III et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310\u20131319","journal-title":"N Engl J Med"},{"key":"8407_CR22","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320\u20131328","journal-title":"N Engl J Med"},{"key":"8407_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, Bosaily AE-S, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822","journal-title":"Lancet"},{"key":"8407_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"M van der Leest","year":"2019","unstructured":"van der Leest M, Cornel E, Isra\u00ebl B et al (2019) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naive men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol 75:570\u2013578","journal-title":"Eur Urol"},{"key":"8407_CR25","doi-asserted-by":"publisher","unstructured":"Klotz L, Chin J, Black PC et al\u00a0(2021) Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial. JAMA Oncol 7(4):534\u2013542. https:\/\/doi.org\/10.1001\/jamaoncol.2020.7589","DOI":"10.1001\/jamaoncol.2020.7589"},{"key":"8407_CR26","doi-asserted-by":"publisher","unstructured":"Sathianathen NJ, Omer A, Harriss E et al\u00a0(2020) Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis. Eur Urol 78(3):402\u2013414. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.048","DOI":"10.1016\/j.eururo.2020.03.048"},{"key":"8407_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/bju.14809","volume":"124","author":"N Guidance","year":"2019","unstructured":"Guidance N (2019) Prostate cancer: diagnosis and management. BJU Int 124:9\u201326","journal-title":"BJU Int"},{"key":"8407_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR\/ultrasound fusion\u2013guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313:390\u2013397","journal-title":"JAMA"},{"key":"8407_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00345-019-02707-9","volume":"38","author":"IG Schoots","year":"2020","unstructured":"Schoots IG, Roobol MJ (2020) Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions. World J Urol 38:517\u2013529","journal-title":"World J Urol"},{"key":"8407_CR30","doi-asserted-by":"publisher","first-page":"e0201384","DOI":"10.1371\/journal.pone.0201384","volume":"13","author":"S Punnen","year":"2018","unstructured":"Punnen S, Nahar B, Soodana-Prakash N et al (2018) Optimizing patient\u2019s selection for prostate biopsy: a single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer. PLoS One 13:e0201384","journal-title":"PloS one"},{"key":"8407_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/bju.14098","volume":"121","author":"SC Druskin","year":"2018","unstructured":"Druskin SC, Tosoian JJ, Young A et al (2018) Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer. BJU Int 121:619\u2013626","journal-title":"BJU Int"},{"key":"8407_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.juro.2014.01.030","volume":"192","author":"F Porpiglia","year":"2014","unstructured":"Porpiglia F, Russo F, Manfredi M et al (2014) The roles of multiparametric magnetic resonance imaging, PCA3 and Prostate Health Index\u2014which is the best predictor of prostate cancer after a negative biopsy? J Urol 192:60\u201366","journal-title":"J Urol"},{"key":"8407_CR33","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/pros.23401","volume":"77","author":"RJ Hendriks","year":"2017","unstructured":"Hendriks RJ, van der Leest MMG, Dijkstra S et al (2017) A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection. Prostate 77:1401\u20131407. https:\/\/doi.org\/10.1002\/pros.23401","journal-title":"Prostate"},{"key":"8407_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.euo.2019.08.015","volume":"3","author":"UG Falagario","year":"2020","unstructured":"Falagario UG, Martini A, Wajswol E et al (2020) Avoiding unnecessary magnetic resonance imaging (MRI) and biopsies: negative and positive predictive value of MRI according to prostate-specific antigen density, 4Kscore and risk calculators. Eur Urol Oncol 3:700\u2013704. https:\/\/doi.org\/10.1016\/j.euo.2019.08.015","journal-title":"Eur Urol Oncol"},{"key":"8407_CR35","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","volume":"30","author":"M de Rooij","year":"2020","unstructured":"de Rooij M, Isra\u00ebl B, Tummers M et al (2020) ESUR\/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists\u2019 training. Eur Radiol 30:5404\u20135416. https:\/\/doi.org\/10.1007\/s00330-020-06929-z","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08407-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-08407-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-08407-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T17:36:30Z","timestamp":1647279390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-08407-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["8407"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-08407-6","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"25 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Leonardo Kayat Bittencourt.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Karolina Guricova and Jared C. Durieux (co-authors) kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}